SCHEMBL5584738

SCHEMBL5584738

CN(C)S(=O)(=O)c1cc2c(O)cccc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.39
LMNA P02545 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAOA P21397 2/20 0.38
AKR1B1 P15121 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA9 Q16790 1/20 0.37
RAB9A P51151 3/20 0.36
AR P10275 1/20 0.36
CA2 P00918 1/20 0.36
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10507437 0.80 CA2 (0.56) MEN1KMT2AMAPTMAOACA12
SCHEMBL5584659 0.79 MAOA (0.39) MEN1KMT2AMAPTMAOACA12
SCHEMBL5584574 0.79 CA2 (0.53) LMNAMEN1KMT2AALDH1A1MAPT
SCHEMBL29090879 0.73 CA2 (0.61) LIPGLMNAALDH1A1MAPTMAPK1
SCHEMBL5585001 0.73 ALDH1A1 (0.44) LMNAMEN1KMT2AALDH1A1MAPT
SCHEMBL2268151 0.69 MAOA (0.44) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL9351766 0.68 CDK2 (0.61) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL29654178 0.67 HPGD (0.58) LMNAMEN1KMT2AALDH1A1MAPT
SCHEMBL9923790 0.67 KDM4E (0.50) MEN1KMT2AMAPTMAOAAKR1B1
SCHEMBL5584152 0.67 KDM4E (0.65) LMNAMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196199-B2 Antiserotonine agents; antidepressants MITSUBISHI PHARMA CORPORATION (JP) 2007-03-27 US disclosed
US-7196199-B2 Antiserotonine agents; antidepressants MITSUBISHI PHARMA CORPORATION (JP) 2007-03-27 US disclosed
US-7196199-B2 Antiserotonine agents; antidepressants MITSUBISHI PHARMA CORPORATION (JP) 2007-03-27 US disclosed
EP-1188747-B1 PHENOXYPROPYLAMINE COMPOUNDS MITSUBISHI PHARMA CORP (JP) 2005-09-07 EP disclosed
US-20040138227-A1 Phenoxypropylamine compounds NISHIYAMA AKIRA 2004-07-15 US disclosed
US-6720320-B2 ANTISEROTONINE AGENTS MITSUBISHI PHARMA CORPORATION (JP) 2004-04-13 US disclosed
US-20020111358-A1 Phenoxypropylamine compounds MITSUBISHI PHARMA CORPORATION (JP) 2002-08-15 US disclosed
EP-1188747-A1 PHENOXYPROPYLAMINE COMPOUNDS Mitsubishi Pharma Corporation (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138227-A1 Phenoxypropylamine compounds HTR1A, HTR1D, HTR5A LIPG 4858/4885LMNA 3559/4885MEN1 2975/4885
US-20020111358-A1 Phenoxypropylamine compounds HTR1A, HTR1D, HTR5A LIPG 4858/4885LMNA 3559/4885MEN1 2975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.